Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wyatt

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Frontiers in Immunology|June 9, 2018
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing AntibodiesShridhar Bale, Alexandra Martiné, Richard Wilson, et al.
Journal of Virology|February 21, 2012
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4Emilia Falkowska, Alejandra Ramos, Yu Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesignKaren Tran, Christian Poulsen, Javier Guenaga, et al.
Environmental Microbiology|July 22, 2014
Functionality and prevalence of trehalose-based oligosaccharides as novel compatible solutes in ascospores of Neosartorya fischeri (Aspergillus fischeri) and other fungiTimon T Wyatt, M Richard van Leeuwen, Elena A Golovina, et al.
Pharmaceutics|July 27, 2022
Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper LiposomesDominik Damm, Ehsan Suleiman, Hannah Theobald, et al.
Journal of Virology|April 15, 2011
Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaquesAndreas Mörner, Marianne Jansson, Evelien M Bunnik, et al.
Nature Communications|May 18, 2018
Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimerAnita Sarkar, Shridhar Bale, Anna-Janina Behrens, et al.
Journal of Virology|October 17, 2008
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodiesNicole A Doria-Rose, Rachel M Klein, Maura M Manion, et al.
Journal of Virology|August 25, 2017
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman PrimatesYimeng Wang, Sijy O'Dell, Hannah L Turner, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 5, 2023
Modulation of immune responses to liposomal vaccines by intrastructural helpDominik Damm, Ehsan Suleiman, Jannik T Wagner, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Frontiers in Immunology|June 9, 2018
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing AntibodiesShridhar Bale, Alexandra Martiné, Richard Wilson, et al.
Journal of Virology|February 21, 2012
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4Emilia Falkowska, Alejandra Ramos, Yu Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesignKaren Tran, Christian Poulsen, Javier Guenaga, et al.
Environmental Microbiology|July 22, 2014
Functionality and prevalence of trehalose-based oligosaccharides as novel compatible solutes in ascospores of Neosartorya fischeri (Aspergillus fischeri) and other fungiTimon T Wyatt, M Richard van Leeuwen, Elena A Golovina, et al.
Pharmaceutics|July 27, 2022
Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper LiposomesDominik Damm, Ehsan Suleiman, Hannah Theobald, et al.
Journal of Virology|April 15, 2011
Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaquesAndreas Mörner, Marianne Jansson, Evelien M Bunnik, et al.
Nature Communications|May 18, 2018
Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimerAnita Sarkar, Shridhar Bale, Anna-Janina Behrens, et al.
Journal of Virology|October 17, 2008
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodiesNicole A Doria-Rose, Rachel M Klein, Maura M Manion, et al.
Journal of Virology|August 25, 2017
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman PrimatesYimeng Wang, Sijy O'Dell, Hannah L Turner, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 5, 2023
Modulation of immune responses to liposomal vaccines by intrastructural helpDominik Damm, Ehsan Suleiman, Jannik T Wagner, et al.
Pageof 17